Early treatment with lorlatinib improves survival in some lung cancer patients

Lung cancer patients with a specific genetic alteration lived longer and were protected against metastasis to the brain when treated early with the drug lorlatinib (Lorbrena), according to a study led by researchers at Massachusetts General Hospital (MGH), published in the New England Journal of Medicine (NEJM). Non-small-cell lung cancer (NSCLC) accounts for 87% of […]

Continue Reading

Study questions blood pressure drug guidance based on age and ethnicity

No evidence found to support differing advice according to age and ethnicity Current UK guidance on drug treatment for high blood pressure—which differs depending on a patient’s age and ethnicity—could be simplified in line with other international guidelines, suggests a study published by The BMJ. The results show similar reductions in blood pressure for three […]

Continue Reading

Commentary: Want to understand health disparities? Get your antiracist goggles on

When it comes to understanding why children from non-white race groups have such poor health outcomes compared with their white counterparts, it’s time for researchers to look beyond their genes and delve deeper into social factors, according to a commentary published today in the journal Pediatrics. “Framing race in biological terms within health sciences is […]

Continue Reading

Controversy continues over ’13 Reasons Why’ and adolescent suicide

After its release in 2017, the Netflix series “13 Reasons Why” spurred controversy over concerns that its portrayal of a teenage girl’s suicide could increase suicide contagion among adolescents. Though a much-publicized 2019 study found a contagion effect among boys, a subsequent reanalysis of that data by the Annenberg Public Policy Center (APPC) of the […]

Continue Reading